2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
3
Peripheral Nervous System Diseases
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Stomach Neoplasms
2
Pseudomyxoma Peritonei
2
Ototoxicity
2
Neurofibromatosis 1
2
Neoplasms
2
Liver Neoplasms
2
Hearing Loss
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Weight Loss
1
Ulcer
1
Tongue Neoplasms
1
Tomaculous neuropathy
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Renal Artery Obstruction
1
Radiation-Induced Mucositis
1
Radiation Pneumonitis
1
Pulmonary Embolism
1
Primary Myelofibrosis
1
Primary Graft Dysfunction
1
Interventions
Bupivacaine
3
Lidocaine
2
Botulinum Toxins, Type A
2
Ultrasonography
1
Therapeutics
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Ralfinamide
1
Radiofrequency Ablation
1
Nerve Conduction Studies
1
Musculoskeletal Manipulations
1
Methylprednisolone
1
Lidoderm
1
Injections
1
Indocyanine Green
1
Electromyography
1
Dry Needling
1
Decompression
1
Cryosurgery
1
Cholecalciferol
1
Bevacizumab
1
Anesthetics, Local
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroma
×
Acetylcysteine
×
Clear all
NCT04460521
2024-08-23
ACTS
Nova Scotia Health Authority
Phase 4
Recruiting
240 enrolled